NIH-funded research R01 grant

Impact of maternal substance use on offspring neurobehavioral development

Funded at Massachusetts General Hospital · NIH-11473971 · Data updated 2026-11-12

A study with pregnant people who use substances to understand how their immune system and the placenta affect their child’s brain development and behavior over time.

More Substance Use research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$1,807,374
NIH project number4R01HD113188-02
Project IDNIH-11473971 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are pregnant individuals with indicated exposure to opioids, cannabis, or alcohol and their offspring, followed through early childhood.

Less likely to help

Results may be less directly beneficial for pregnant individuals without substance exposure or for children without exposure-related risks.

What this research studies

This project uses data from a large, multi-site study to follow mothers and their children from birth to early childhood. It will look at how substance use during pregnancy influences maternal immune activation and how that relates to the child’s neurodevelopment and behavior, including mood and attention-related outcomes. The researchers will examine the placenta’s role in mediating these effects and connect findings to serotonin pathways in the developing brain. The work aims to uncover mechanisms that could inform prevention and early intervention for children at risk.

Why it matters

Potential benefit: If successful, findings could guide strategies to reduce neurodevelopmental risk in children exposed to substances in pregnancy and improve early-life monitoring and care.

How similar studies have gone: The study builds on large-scale, human cohorts examining maternal immune and placental factors influencing child development, with prior work showing links between exposure and neurodevelopmental outcomes.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Edlow, Andrea Goldberg — Massachusetts General Hospital
  • Study coordinator: Edlow, Andrea Goldberg

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.